5
CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPUETIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACID FOR USE IN THE TREATMENT OF CANCER, HIV AND AIDS-RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS, VIRAL AND BACTIERIAL DISEASES, CANCER AND CYSTIC FIBROSIS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACUETICAL PREPARATIONS FOR THE TREATMENT OF CYSTIC FIBROSIS
10
INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; SURGICAL AND MEDICAL APPARATUS AND INSTRUMENTS, NAMELY, SYRINGES, SCALPELS, CATHETERS AND TUBES FOR MEDICAL SERVICES
42
genetic engineering services and biotechnology services, namely, development and commercialization of therapeutic vaccines and gene-based therapies in respect of oncology and neurotherapy